Item 8.01 Other Events
On October 1, 2025, SWK Holdings Corporation (NASDAQ: SWKH), a life-science focused specialty finance company, announced the full repayment of its loan to Elutia, Inc. ("Elutia") upon receipt of a $27.8 million payoff payment from Elutia, including outstanding principal, exit fees, and accrued interest.
This payoff follows the closing of Elutia's previously announced sale of its BioEnvelope business to Boston Scientific Corporation for $88.0 million in cash.
The $27.8 million payoff exceeds the Company's net GAAP carrying value of $23.9 million as of June 30, 2025.The Company expects to recognize approximately $1.4 million of incremental income from the acceleration of exit fee recognition and $1.4 million from the release of loan loss reserves.